IP Library Granted Patent US 9,724,302
Granted Patent B2
US 9,724,302 · App. 13/786,378 · Granted Aug 8, 2017

Method for formulating large diameter synthetic membrane vesicles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,724,302
App. No.
13/786,378
Granted
Aug 8, 2017
Kind
B2
Abstract

The present invention generally relates to the field of pharmaceutical sciences. More specifically, the present invention includes apparatus and devices for the preparation of pharmaceutical formulations containing large diameter synthetic membrane vesicles, such as multivesicular liposomes, methods for preparing such formulations, and the use of specific formulations for therapeutic treatment of subjects in need thereof. Formation and use of the pharmaceutical formulations containing large diameter synthetic membrane vesicles produced by using the apparatus and devices for therapeutic treatment of subjects in need thereof is also contemplated.

Claims (44)

1. A continuous processing system, comprising:

a first concentrator unit comprising:

a first retentate vessel;

a first particle suspension inlet line, connected to the first retentate vessel;

a first outlet line, connecting the first retentate vessel and a first hollow fiber tangential flow filter;

a first solution inlet line;

a first sterilizing hydrophilic filter, connecting the first retentate vessel and the first solution inlet line;

a first pump located along the first outlet line between the first retentate vessel and the first hollow fiber tangential flow filter;

a second outlet line, leading to a second concentrator unit,

said second concentrator unit comprising:

a second retentate vessel;

a second particle suspension inlet line, connected to the second retentate vessel and the second outlet line;

a third outlet line, connecting the second retentate vessel and a second hollow fiber tangential flow filter;

a second solution inlet line;

a second sterilizing hydrophilic filter, connecting the second retentate vessel and the second solution inlet line; and

a second pump located along the third outlet line between the second retentate vessel and the second hollow fiber tangential flow filter.

2. The system of claim 1 , further comprising a new suspending medium inlet line connected to the first retentate vessel.

3. The system of claim 1 , wherein the continuous processing system is a continuous-flow particle-concentration system or continuous phase exchange system.

4. The system of claim 1 , further comprising an evaporation apparatus,

connected to the first particle suspension inlet line,

wherein the evaporation apparatus comprises:

at least one atomizing nozzle apparatus and a solvent removal vessel having a top, a bottom and a circular wall for removing an organic solvent from a droplet, wherein at least one atomizing nozzle apparatus comprises:

a first fluid conduit and a second fluid conduit each having at least one entrance orifice and at least one exit orifice;

a fluid contacting chamber having a top comprising at least one entrance orifice and having a bottom comprising at least one exit orifice and connecting to the at least one exit orifice of the first fluid conduit and the at least one exit orifice of the second fluid conduit; and

a third fluid conduit, wherein the third fluid conduit annularly surrounds a portion of the fluid contacting chamber, and

wherein the solvent removal chamber comprises:

a carrier gas entrance orifice;

a solvent removal gas exit orifice centrally connected to the top; and

a product exit orifice connected to the bottom of the solvent removal vessel.

5. The system of claim 4 , wherein the at least one exit orifice of the fluid contacting chamber and the at least one exit orifice of the third fluid conduit are flush.

6. The system of claim 4 , wherein the at least one exit orifice of the fluid contacting chamber is recessed within the at least one exit orifice of the third fluid conduit.

7. The system of claim 4 , wherein the at least one exit orifice of the fluid contacting chamber extends beyond the at least one exit orifice of the third fluid conduit.

8. The system of claim 4 , wherein the first fluid conduit and the second fluid conduit are co-axial for a first portion of the first fluid conduit length.

9. The system of claim 4 , wherein the second fluid conduit annularly surrounds a first portion of the first fluid conduit.

10. The system of claim 4 , wherein a diameter of the fluid contacting chamber is larger than a diameter of the first fluid conduit.

11. The system of claim 4 , wherein the fluid contacting chamber conically narrows in diameter from the top of the fluid contacting chamber to the bottom of the fluid contacting chamber.

12. The system of claim 4 , wherein the fluid contacting chamber conically narrows in diameter from a point below the top of the fluid contacting chamber to the bottom of the fluid contacting chamber.

13. The system of claim 4 , wherein the at least one exit orifice of the first fluid conduit and the at least one exit orifice of the second fluid conduit are flush with each other.

14. The system of claim 4 , wherein the atomizing nozzle is mounted to and extending through the top of the solvent removal vessel.

15. The system of claim 4 , further comprising a rinse nozzle mounted to and extending through the top of the solvent removal vessel.

16. The system of claim 4 , wherein the circular wall has a central axis and the solvent removal gas exit orifice further comprises a tube extending into the solvent removal vessel residing along the central axis.

17. The system of claim 4 , wherein the solvent removal gas exit orifice further comprises a tube extending into the solvent removal vessel, wherein the tube is fitted with a narrowing cone.

18. The system of claim 4 , wherein the solvent removal gas exit orifice further comprises a tube extending into the solvent removal vessel, wherein the tube is fitted with a narrowing cone and an annular ring.

19. The system of claim 4 , wherein the solvent removal gas exit orifice diameter is less than 1/10 of a diameter of the inside of the solvent removal vessel wall.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Dec 5, 2025
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 073779/0532 →
SECURITY INTEREST Recorded Jul 4, 2025
From: PACIRA PHARMACEUTICALS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 071814/0792 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 31, 2023
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 063213/0864 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Mar 31, 2023
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 063214/0108 →
SUPPLEMENTAL CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Dec 14, 2021
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; FLEXION THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058516/0636 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2015
From: SCHUTT, ERNEST GEORGE; MCGUIRE, RONALD WARREN; WALTERS, PETER ANDREW; LOS, KATHLEEN D.A.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 037077/0554 →